Introduction
ID-proteins are dominant negative inhibitors of basic helix-loop-helix (bHLH) transcription factors. In contrast to all other bHLH factors, these proteins lack the basic DNA-binding domain, and thus they can antagonize the transcriptional activity of bHLH factors by forming DNA-binding incompetent heterodimers (Benezra et al., 1990) . Four mammalian ID-proteins, ID1-4, have thus far been identified (Benezra et al., 1990; Christy et al., 1991; Sun et al., 1991; Riechmann et al., 1994) . They exhibit similar binding affinities to the various bHLH proteins but exhibit different expression patterns and share strong sequence homologies only in the helix-loop-helix domain (Riechmann et al., 1994) . Overexpression of ID-proteins, specifically overexpression of ID1, has been detected in various human tumors, and in some cases is correlated with poor clinical prognosis (Kleeff et al., 1998; Maruyama et al., 1999; Kebebew et al., 2000; Langlands et al., 2000; Lin et al., 2000; Hu et al., 2001; Polsky et al., 2001; Schindl et al., 2001 Schindl et al., , 2003 Takai et al., 2001; Schoppmann et al., 2003) . However, it is not clear whether ID1 overexpression directly contributes to malignant progression or merely reflects enhanced proliferation. The expression of IDproteins is induced as part of the immediate-early transcriptional response to growth factors, and is regulated in a cell cycle-dependent manner. ID-proteins are necessary for G1 to S-phase transition (Christy et al., 1991; Deed et al., 1993; Barone et al., 1994; Hara et al., 1994; Peverali et al., 1994; Biggs et al., 1995) , and ID2 and ID3 are phosphorylated during G1 to S-phase transition by cyclin-dependent kinase (CDK) 2 (CDK2)/ cyclin A or CDK2/cyclin E complexes (Deed et al., 1997; Hara et al., 1997) . This phosphorylation event may be a trigger for their ubiquitin-mediated proteasomal degradation and/or alter their bHLH protein binding specificities (Bounpheng et al., 1999; Deed et al., 1997) . Various functions of the individual ID-proteins have been described to date: inhibition of differentiation by interfering with differentiation-specific bHLH factors (Benezra et al., 1990; Jen et al., 1992; Kreider et al., 1992) , interference with non-bHLH transcription factors (Ohtani et al., 2001; Roberts et al., 2001) , induction of apoptosis (Florio et al., 1998; Tanaka et al., 1998; Andres-Barquin et al., 1999) , cooperation with the pRb pathway (Iavarone et al., 1994; Hara et al., 1996) , and extension of life span (Alani et al., 1999; Nickoloff et al., 2000; Tang et al., 2002) . These biological activities are consistent with the model that ID-proteins may directly contribute to tumorigenesis.
Malignant cells are characterized by a plethora of alterations that affect the control of growth and differentiation as well as other cellular functions (Hanahan and Weinberg, 2000) . A large number of human cancer cells exhibit numerical and/or structural abnormalities of centrosomes, cellular organelles that regulate critical cellular activities including cell cycle progression, mitosis, cytokinesis, and cell polarity (Doxsey, 2001 ). Centrosomes function as major microtubule organizing centers both in mitotic and postmitotic cells and consist of a pair of centrioles surrounded by pericentriolar material. In normal cells, the centrosome duplicates in synchrony with the cell division cycle. After cell division, cells contain a single centrosome that contains two centrioles. In parallel with S-phase progression, the centrosome is licensed for duplication and the two centrioles split apart. Each centriole then serves as a template for the synthesis of a new daughter centriole. This process is coupled to the cell division cycle to generate a bipolar mitotic spindle, which ensures equal chromosome segregation during each mitosis (reviewed in Meraldi and Nigg, 2002) . CDK2 in complex with cyclin A and/or cyclin E has been proposed to link centrosome duplication to Sphase progression (Hinchcliffe et al., 1999; Lacey et al., 1999; Matsumoto et al., 1999; Meraldi et al., 1999) , but other cell cycle regulators and tumor suppressors also impinge on the centrosome duplication cycle (reviewed in D' Assoro et al., 2002) . With respect to cancer development and progression, defects in centrosome duplication are thought to contribute to genomic instability by formation of abnormal multipolar mitoses that can result in chromosome misegregation and can lead to aneuploidy (Boveri, 1914; Salisbury et al., 1999) . Deregulation of centrosome duplication leading to supernumerary centrosomes has been observed as a consequence of loss of function of various tumor suppressor genes or expression of cellular or viral oncogenes Xu et al., 1999; Duensing et al., 2000; Mussman et al., 2000; Tarapore et al., 2001; D'Assoro et al., 2002; Tarapore and Fukasawa, 2002) .
Here, we show that a fraction of ID1 localizes to centrosomes and mitotic spindle poles. This may be functionally relevant as overexpression of ID1, but not the other family members that do not localize to centrosomes, induces supernumerary centrosomes. These results suggest that ID1 plays a role in the coordination of cellular processes related to centrosomes and mitotic spindle poles, and that aberrant expression levels of ID1 as found in many human tumors may disrupt the normal control of centrosome duplication.
Results

A fraction of ID1 localizes to centrosomes
The localization of the ID-proteins has been described as nuclear and/or cytoplasmic, depending on the type and cell cycle state of the cell (Jen et al., 1992; Iavarone et al., 1994; Deed et al., 1996) . We performed immunofluorescence-staining experiments for the different IDproteins in various cell types. Immunoreactivity for ID1, ID2, and ID3 was readily detectable as strong cytoplasmic and/or nuclear staining, depending on the cell type and the antibody used ( Figure 1a ). In addition, however, we consistently detected specific staining of ID1 in mitotic cells that localized to the mitotic spindle poles. This was corroborated by colocalization of the ID1-signal with the pericentriolar protein g-tubulin using the ID1 C-20 antibody (Figure 1b) . To confirm the specificity of the centrosomal ID1-signal, we tested two additional commercially available antibodies against ID1. In each case, we detected specific colocalization of a fraction of the ID1-signal to centrosomes. The Z-8 antibody detected centrosomal ID1 staining in mitotic cells (data not shown), the JC-FL antibody revealed centrosomal ID1 staining in interphase cells (data not shown), and the C-20 antibody revealed centrosomal ID1 localization throughout the cell division cycle (Figure 1b) . Importantly, no centrosomal staining of ID1 was detected in ID1 À/À mouse embryo fibroblasts (MEFs), whereas centrosomal staining was detected in wild-type MEFS (Figure 1c ). Immunofluorescence experiments with primary human foreskin fibroblast (HFF), normal oral keratinocytes (NOK), the keratinocyte cell line HaCaT, as well as with the human osteosarcoma cell lines U2OS and Saos-2 each revealed centrosomal localization of ID1 (data not shown). Moreover, centrosomal localization of ID1 was also confirmed by immunoblot analyses of centrosomal fractions derived from HaCaT keratinocytes (data not shown).
Stable ectopic expression of ID1 in primary cells results in accumulation of cells with abnormal centrosome numbers
High level expression of ID-proteins is frequently observed in a variety of human tumors and particularly in the case of ID1 has been correlated with poor clinical outcome (Kleeff et al., 1998; Maruyama et al., 1999; Kebebew et al., 2000; Langlands et al., 2000; Lin et al., 2000; Hu et al., 2001; Polsky et al., 2001; Schindl et al., 2001 Schindl et al., , 2003 Takai et al., 2001; Schoppmann et al., 2003) . To investigate whether ectopic expression of ID1 affects centrosome numbers, we established human foreskin keratinocyte (HFK) populations that stably expressed ID1, ID2, ID3, or ID4. HFK populations expressing ID1, but not those expressing ID2, ID3, or ID4, contained an increased number of cells with more than two centrosomes (Figure 2a) . Quantification of cells with abnormal centrosome number showed a 2-3-fold increase (Po0.001) of cells with abnormal centrosome numbers of more than two centrosomes in mononuclear ID1-expressing cells (Figure 2b ). In addition, these cell populations contained an increased number of cells with abnormal centrosome numbers, and these accumulated in parallel with nuclear atypias such as multinucleation (Duensing et al., 2001) . The expression of ID-proteins was confirmed by immunoblotting ( Figure 2c ). FACS analysis of ID-expressing populations did not reveal significant differences in cell cycle distribution or ploidy (data not shown). To test whether the ability of ID1 to induce centrosome abnormalities was cell type specific, we also established ID-expressing cell populations of primary HFFs. As in HFKs, we observed a significant eightfold increase (Po0.001) of cells with abnormal centrosome numbers, specifically in the ID1-expressing populations ( Figure 2b ).
Transient expression of ID1 results in abnormal centrosome numbers
To determine whether the observed effect of ID1 on centrosome homeostasis reflects an immediate effect due to interference with centriole synthesis, we performed transient transfection experiments. U2OS cells with individual centrioles marked with GFP due to stable expression of Centrin-GFP (Paoletti et al., 1996; Duensing et al., 2001) were transfected with 10 mg of ID-expression plasmid and 1 mg of DsRed as a transfection marker. Only DsRed-positive cells were scored for centriole numbers at 36-48 h after transfection ( Figure 3a ). Ectopic expression of ID1 resulted in a threefold increase (Po0.001) of cells with abnormal centriole numbers (n44) (Figure 3b ), whereas expression of ID2, ID3, or ID4 did not have a similar effect. The expression of ID-proteins was verified by immunoblotting ( Figure 3c ). To determine whether this activity of ID1 was dependent on the pRb or p53 tumor suppressors, we also performed transient transfection experiments in Saos-2 cells, in which both of these tumor suppressors are mutated (Lauricella et al., 2001) . Centrosomes were stained with an antibody against g-tubulin and cells with more than two centrosomes were considered abnormal. Although Saos-2 cells exhibited a higher background level of cell with supernumerary centrosomes, these experiments documented a similar twofold increase (Po0.001) in cells with abnormal centrosome numbers upon ID1 expression (Figure 3b ). To test whether all our ID expression constructs produced functionally active proteins, luciferase assays in U2OS cells using a reporter construct driven by the human p21 Waf1/Cip1 promoter, pWps-Luc (Hasskarl et al., 2000) were performed. Cotransfection of equal amounts of each of the ID expression constructs resulted in comparable levels of repression of p21
Waf1/Cip1 basal promoter activity (Figure 3d ).
HLH region and the N-terminus are necessary for the induction of centrosome abnormalities
To map the regions of ID1 that contribute to induction of centrosome abnormalities, several mutants of human ID1 analogous to the mouse-ID1 mutants described by Pesce and Benezra (1993) were generated ( Figure 4a ). These include ID1-V98G, which contains a point mutation in the second helix domain at amino acid 98 resulting in a substitution of V to G that disrupts HLH dimerization, corresponding to the V91P mutant in murine Id1; ID1-DNH2, which lacks the amino terminal 64 amino acids, and ID1-DCOOH, which lacks the carboxy terminal 44 amino acids. Stable HFK populations expressing each of these ID1 mutants were generated. The corresponding proteins were expressed at similar levels ( Figure 4b ). Centrosomes were visualized by g-tubulin staining and mononuclear cells with more than two centrosomes were scored as abnormal. Consistent with previous results, cells expressing wildtype ID1 showed a threefold increase (Po0.001) of cells with centrosome abnormalities (Figure 4c) . A similar increase in cells with supernumerary centrosomes was also observed in the population expressing the Waf1/Cip1 promoter or the parental vector pBl (P) along with 500 ng of the indicated ID expression plasmids. Each transfection also contained TK-promoter-driven renilla luciferase as a transfection control. Representative results of three independent experiments7s.d.
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carboxy-terminal deletion mutant (Po0.001), whereas cells expressing the HLH mutant or the amino-terminal truncation mutant did not exhibit any centrosome abnormalities (Figure 4c) . Thus, the integrity of the HLH domain as well as the amino terminus, but not the carboxy terminus, is necessary for the ability of ID1 to induce centrosome abnormalities. Similar results were obtained upon transient transfection into U2OS/Centrin-GFP cells. (Figure 4b and c) . The ability to induce centrosome abnormalities was not related to induction of cell proliferation as no major differences in 5-bromo-2 0 -deoxyuridine (BrdU) incorporation between the different cell populations was observed (Figure 4d ). Given the high-level expression of these mutants in the transfected cell populations, we were unable to unambiguously correlate induction of centrosome abnormalities to centrosomal localization with these mutants.
Discussion
High level of ID1 expression is often observed in primary tumor specimens (Polsky et al., 2001; Schindl et al., 2001; Takai et al., 2001; Schoppmann et al., 2003) . Despite the finding that ID1 expression correlates with poor clinical outcome, it is not clear to date whether increased ID1 expression is merely a marker of increased proliferation, as ID1 is mainly expressed in proliferating cells, or whether ID1 directly exerts an oncogenic effect. In support of the latter model, we and others have shown previously that ectopic expression of ID1 can extend the life span of primary HFKs (Alani et al., 1999; Nickoloff et al., 2000; Tang et al., 2002) . In addition, ID1 has been implicated in neoangiogenesis (Lyden et al., 1999) . Immunofluorescence analyses of the various ID-proteins and the centrosomal marker protein g-tubulin revealed that a fraction of endogenous ID1 localizes to centrosomes and mitotic spindle poles. This colocalization was most prominent in mitotic cells but also detectable in all other phases of the cell cycle (Figure 1b) . Centrosomal staining of ID1 was observed with three different antibodies and was absent in ID1
À/À MEFs ( Figure 1c ). In addition, the centrosomal ID1 signal was blocked by the peptide against which the C-20 antibody was generated, and ID1 was also detected by immunoblot analysis in centrosome fractions. Interestingly, punctuate staining patterns of ID1 that might represent centrosomal staining have been reported using immunohistochemistry analyses of human tumor specimens Schoppmann et al., 2003) .
The finding that a fraction of endogenous ID1 localizes to centrosomes led us to investigate the impact of ID expression on centrosome duplication. These studies revealed that primary human cells engineered to express ID1 accumulated abnormal centrosome numbers. In contrast, cells that expressed ID2, ID3, or ID4, did not exhibit centrosome abnormalities. This accumulation of supernumerary centrosomes was observed in primary HFKs as well as fibroblasts. Transient expression studies in tumor cell lines showed that ID1 could rapidly induce abnormal centrosome and centriole numbers similar to what was described for the human papillomavirus type 16 (HPV-16) E7 oncoprotein (Duensing et al., 2000) . Various viral and cellular oncoproteins and mutations of tumor suppressor genes can lead to centrosome abnormalities Xu et al., 1999; Duensing et al., 2000) and the induction of supernumerary centrosomes has been suggested to contribute to carcinogenesis by inducing multipolar mitoses thus reducing mitotic fidelity (reviewed in Nigg, 2002) . Primary human cells with ectopic ID1 expression, however, do not exhibit gross aneuploidy (data not shown). Therefore, the centrosomal localization of ID1 and the ability to induce abnormal centrosome numbers may not be sufficient to trigger mitotic infidelity in an otherwise normal human cell. One possibility is that checkpoint control mechanisms that prevent cells with multipolar mitotic spindles to enter and complete mitosis are still intact in ID1-overexpressing cells. Alternatively, ID1 may exert regulatory functions at the centrosome that are not directly related to the control of the centrosome duplication cycle and excessive levels of ID1 expression may lead to abnormal centrosome numbers through an indirect mechanism. In support of this notion, there is a Interference of ID1 with either the pRb or the p53 tumor suppressor pathway is unlikely to contribute to the observed cellular phenotype, since ID1 was able to induce centrosome abnormalities in SaOS-2 human osteosarcoma cells that contain mutated p53 and pRb (Lauricella et al., 2001) . ID-proteins have been shown do inhibit the expression of the CDK-inhibitory proteins p16
Waf1/Cip1 , and p27 Kip1 (Lasorella et al., 1996; Prabhu et al., 1997; Pagliuca et al., 2000; Alani et al., 2001; Ohtani et al., 2001; Matsumura et al., 2002; Mueller et al., 2002; Tang et al., 2002) . Since all IDproteins were able to inhibit expression of a p21
Waf1/Cip1 reporter construct, we consider it unlikely that ID1 induces centrosome abnormalities through inhibition of p21
Waf1/Cip1 even though repression of p21 Waf1/Cip1 using antisense constructs in human hematopoietic cells results in centrosome abnormalities (Mantel et al., 1999) . This does not rule out, however, that there are small differences between the ID family members to repress p21
Waf1/Cip1 or p27 Kip1 that are not detected by the reporter assay used here, and that are sufficient to affect centrosome numbers. Even though ID1 can interfere with Ets-mediated activation of p16 INK4A , and it has been suggested that ID1 may directly repress p16 INK4A expression Ohtani et al., 2001 ), this activity is not unique to ID1 (Pagliuca et al., 2000) . Furthermore, Saos-2 cells express high levels of p16 INK4A and U2OS cells do not express any detectable p16 INK4A and ID1 was able to induce centrosome abnormalities in both cell types. In addition, we have recently shown that loss of p16 INK4A expression on primary human epithelial cells does not give rise to centrosome abnormalities (Piboonniyom et al., 2003) . Moreover, ID-expressing cells do not display differences in cell cycle distribution or in BrdU incorporation when grown under standard culture conditions (data not shown, see Figure 4d ).
To map the domains of ID1 that are necessary for induction of centrosome abnormalities, we generated a set of ID1 mutants. A carboxy-terminal splice variant of ID1 has been described (Nehlin et al., 1997) and the carboxy-terminal portion of ID has been implicated in protein stability, whereas the amino-terminal region of ID1 that lacks the CDK2-consenus phosphorylation site of ID2, ID3 and, ID4 might be involved in the induction of apoptosis (Florio et al., 1998) . A carboxy-terminal truncation mutant was able to induce centrosome abnormalities as efficiently as wild-type ID1, whereas deletion of the amino-terminal 64 amino acids and disruption of the HLH domain abrogated the observed effect on centrosome homeostasis. Thus, the functional integrity of the amino-terminal portion as well as the HLH domain each is necessary for ID1 to cause centrosome abnormalities.
In summary, we have shown that a fraction of ID1 but not of ID2, ID3, or ID4 is localized to centrosomes and mitotic spindle poles. In addition, ectopic expression of ID1 but not the other ID-proteins rapidly results in abnormal centrosome and centriole numbers. Given the central role of the centrosome for the coordination of various cellular processes, these changes may predispose cells to acquire additional alterations that may ultimately promote malignant growth. We propose a model whereby ID1 contributes to carcinogenesis not only indirectly through transcriptional repression of CDK inhibitors and abrogation of cellular differentiation, but through direct interaction with a still to be identified protein at the centrosome, thereby interfering with centrosome homeostasis.
Materials and methods
Cell culture
Primary HFKs were prepared as described previously (Alani et al., 1999) . To establish primary fibroblast cultures (HFFs), dermal sheets of the same foreskin preparation were cut into small pieces and incubated with Trypsin/EDTA. Tissue pieces were sheered several times through a 14-gauge needle and plated on tissue culture dishes. HFKs and NOK were maintained in serum-free keratinocyte growth medium (KGM; GIBCO BRL), supplemented with gentamycin (20 mg/ml), amphotericin B (2.5 mg/ml), penicillin (50 U/ml), and streptomycin (50 mg/ml). HFF, U2OS, and HaCaT cell lines and MEFs were maintained in DMEM with 10% FBS, or 20% FBS for SaOS-2 cells, supplemented with amphotericin B (2.5 mg/ml), penicillin (50 U/ml), streptomycin (50 mg/ml), and glutamine (2 mM).
Transfections
For transient transfections of U2OS, SaOS-2 and HeLa cells, calcium phosphate coprecipitation was used (Chen and Okayama, 1987) . For stable transfection of HFKs and HFFs, cells were transfected using the Fugene s transfection reagent (Roche Molecular Biochemicals, Indianapolis, USA), according to the manufacturer's recommendations. At 24 h after transfection, cells were washed twice with PBS and fresh medium was added. At 48 h after transfection, cells were processed for further experiments or selected with 200 mg/ml (HFKs) or 600 mg/ml (HFFs) G418 for 3 days (HFKs) or 7 days (HFFs). Pooled populations were used for further experiments. Expression plasmids used were: centrin-GFP (D'Assoro et al., 2001), Ha-dnDP1 (Wu et al., 1996) , pCMVneo, pCDNA3 (Invitrogen, Carlsbad, CA, USA), pID1, pID2, pID3, and pID4 (Alani et al., 1999) . For transient transfection experiments, cells were cotransfected with a vector encoding DsRed (BD Clontech, Palo Alto, CA, USA) and only transfected, DsRed-positive cells were analysed. Transfection was monitored by immunoblot detection of the expressed proteins.
Luciferase assay U2OS cells in six-well plates were transfected with 1 mg of the p21 Waf1/Cip1 promoter-driven firefly luciferase reporter plasmid pWps-luc (Hasskarl et al., 2000) together with 500 ng of the indicated expression plasmid. A constant amount of DNA per transfection was insured by adding the parental vector pCMVneo to 3.5 mg total DNA. PWps-luc contains a 2.4-kb fragment of the upstream regulatory region of the human p21
Waf1/Cip1 cloned into the promoter-less vector pBL. Control cells were transfected with pBL. To allow normalization of transfection efficiencies between different plates, each transfection also contained 20 ng of a thymidine kinase promoterdriven renilla luciferase reporter plasmid (pRL-TK). Cells were lysed in 500 ml lysis buffer (Dual-Luciferase Reporter Kit, Promega, Madison, WI, USA) per well, supernatants were collected, and were subjected to the dual luciferase assay with the firefly luciferase activity normalized by renilla luciferase expression.
Immunofluorescence and immunoblotting
For immunofluorescence analysis, cells were grown on coverslips, fixed in 4% p-formaldehyde for 20 min, and permeabilized with 0.5% Triton X-100 (Sigma) in PBS for 15 min, both at room temperature. For colocalization experiments, cells were permeabilized in methanol for 20 min at -201C and rehydrated with PBS. After immunostaining with the indicated antibodies, nuclei were visualized by using Hoechst 33258 DNA dye.
For immunoblot experiments, 100 mg aliquots of cell lysates prepared in EBC buffer (50 mM Tris-HCl, 120 mM NaCl, 1% (v/v) Nonidet P40, (pH 8.0), 0.5 mM PMSF, 1 mg/ml aprotinin and leupeptin, 2 mM NaF, 0.5 mM Na-orthovanadate) were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and electrotransferred to polyvinylidene fluoride membranes (Immobilon P, Millipore). Antigen/antibody complexes were detected after incubation with appropriate horseradish peroxidase-labeled secondary antibodies (Amersham, 1 : 10 000 dilution) and enhanced chemoluminescence (Renaissance Enhanced Luminol Reagent, NEN Life Science Products) and exposure to X-ray films or by electronic capturing with a Fluoromax S MultiImage (BioRad) set up. In some cases, membranes were stripped and reprobed according to the manufacturer's protocol.
Antibodies used were ID1 (C20, Z8 and JC-FL), ID2 (C20), ID3 (C20), ID4 (C20) (Santa Cruz, Santa Cruz, CA, USA), actin (Chemicon, Temecula, CA, USA), g-tubulin GTU-88, Flag M2 (Sigma, Saint Louis, MO, USA), and hemagglutinin (HA) (Roche, Indianapolis, IN, USA).
Cell cycle analysis
BrdU incorporation experiments were performed by immunofluorescence using a commercially available kit following the protocol supplied by the manufacturer (Roche Molecular Biochemicals). Nuclei were counterstained with Hoechst dye and analysed using a Leica DMA epifluorescence microscope equipped with Sony DKC digital camera. At least 500 nuclei were analysed for each data point.
Statistical methods
Student's t-test was used where applicable. The mean percentage and s.e. of at least three independent experiments and at least 100 cells evaluated per experiment are given unless indicated otherwise.
Generation of id1 mutants
ID1 cDNA was PCR cloned from a human foreskin cDNA library using the taqPCR Kit plus Q-solution (Quiagen, Valencia, CA, USA). The sequence of the PCR-cloned fulllength ID1 was confirmed and the clone was subsequently used as a template for generation of the mutants. Primers used were: ID1 5 0 : GGG GAC AAG TTT GTA CAA AAA AGC AGG CTT CGA AGG AGA TAG AAC CAT GAA AGT CGC CAG TGG CAG C; ID1 3 0 : GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC GCG ACA CAA GAT GCG ATC GTC CGC; ID1 DNH2 5 0 : GGG GAC AAG TTT GTA CAA AAA AGC AGG CTT CGA AGG AGA TAG AAC CAT GCT GCT CTA CGA CAT GAA CAA C; ID1 DCOOH 3 0 : GGG GAC CAC TTT GTA CAA GAA AGC TGG GTT CAC GAG TTC AGC TCC AAC TGA AGG TC. The Quickchange kit (Stratagene, LA Jolla, CA, USA) was used to generate the V98G mutant using following primers: ID1 V98Gs: CTC CAG CAC GGC ATC GAC TAC ATC AGG GAC C; ID1 V98Gas: GGT CCC TGA TGT AGT CGA TGC CGT GCT GGA G. PCR-products were cloned into pDONR201 (Invitrogen, Carlsbad, CA, USA). Gateway expression clones used were: pDest12.2 (native), pDest26 (Nterminal 6xHis tag), pDest27 (N-terminal GST tag), pcDNADest53 (N-terminal GFP tag), and Flag-GW (N-terminal Flag-tag). Flag-GW was generated by cloning the FLAG-tag sequence into the EcoRI-HindIII-site of pCDNA3. The Gateway cassette was cloned into the EcoRV site. All sequences were verified by multiple DNA sequencing.
Isolation of centrosomes
Centrosomes from HaCaT cells were isolated following De Souza et al. (2000) .
